Global COVID-19 Vaccine

Global COVID-19 Vaccine Market Research Report: Forecast (2021-2026)

By Vaccine Type (Whole-microbe COVID-19 Vaccine [Inactivated COVID-19 Vaccine, Live Attenuated COVID-19 Vaccine, Viral Vector-Based COVID-19 Vaccine], Protein Subunit-Based COVID-19 Vaccine, Genetic A Read more

  • Healthcare
  • Apr 2021
  • 204
  • HC22064

Market Overview

The COVID-19 vaccine protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by developing an immune response against it.

As per the MarkNtel Advisors' research report, "Global COVID-19 Vaccine Market Analysis, 2021," the market is expected to witness exponential growth in the anticipated timeline. The outburst of the COVID-19 across the globe has endangered millions of lives.

According to WHO, around 2.9 million people died due to COVID-19, which has infused the strong demand for the coronavirus vaccine worldwide. The factors, such as the massive expenditure made by government & private firms toward vaccine development, increasing healthcare expenditure by the countries, and a significant rise in the number of COVID-19 patients, are backing the market growth. Moreover, surging investments in R&D activities, snowballing demand for Covid-19 vaccines, and fast approvals for vaccine trials by health agencies can also promote market growth over the forecast period.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, Russia
Asia-Pacific: China, India, Japan, South Korea, Australia and Others
South America:  Brazil, Rest of South America
Middle East & Africa:  UAE, Saudi Arabia, South Africa
Key Companies Profiled AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc., Pfizer, Bharat Biotech, Serum Institute of India
Unit Denominations USD Million/Billion

 

Market Segmentation

Senior Citizens Acquired Significant Market Share

Based on Patient Class, Senior Citizens acquired a significant part in the Global COVID-19 Vaccine market in 2020. Due to weak immunity and a higher risk of getting severe illnesses, senior citizens are more prone to COVID-19.

Around 78% of the people aged 65 and above died due to COVID-19. Adhering to this, governments introduced various vaccination drives with priority orders that included adults of 65 years and above to be the first groups to receive COVID-19 vaccines, reveals MarkNtel Advisors' in their research report, "Global COVID-19 Vaccine Market Analysis, 2021."

Whole-microbe Approach Witnessing Rapid Growth

In terms of Vaccine Type, the Whole-microbe approach is witnessing rapid growth in the Global COVID-19 Vaccine market. The segment further fragments into Inactivated, Live Attenuated, and Viral Vector-Based COVID-19 Vaccines wherein the inactivated vaccine acquired a considerable market share.

An inactivated vaccine uses viruses that cannot replicate because the genetic material gets destroyed. It then induces a potent antibody to build immune memory so that the body can stay protected against SARS-CoV-2 in the future. Companies such as Sinovac and Sinopharm use inactivated vaccines. 

Global COVID-19 Vaccine Market Research Report: Forecast (2021-2026)

Regional Landscape

India Exhibits Fastest Growth

India is likely to exhibit the fastest growth in the Asia-Pacific region. India is among the largest manufacturer of the vaccine in the world. The country with the second-highest number of infections has propelled the demand for the covid-19 vaccine.

Factors fueling the COVID-19 vaccines market growth include increasing collaboration among the pharma companies for vaccine development and burgeoning investment by the government to ramp up vaccine production.

Covaxin and Covishield are the in-house produced vaccines in India. The introduction of immunization drives by the government and rising investments in R&D activities are the factors imposing a lucrative opportunity for market growth. Currently, only 6.89% of the population has received a single dose of the vaccine. By December 2021, 40% of the total population, and by May 2022, 60% of the populace are likely to get vaccinated.

However, the second wave of the COVID-19 virus has already hit the nation, and the active case count is much higher than the first one. With the burgeoning number of COVID-19 cases, the demand for coronavirus vaccine can upsurge. Hence, it is likely that Asia-Pacific would attain the highest CAGR in the Global Covid-19 Vaccine market over the forecast period.

Market Driver

Investment Made by Government and Private Firm for the Development of the Vaccine 

Governments & several private firms raised significant funds to boost the COVID-19 vaccine production to curb the number of cases and avoid future virus breakout. Companies such as Moderna, Johnson & Johnson, Pfizer- BioNTech, Sanofi-GlaxoSmithKline, Novavax- AstraZeneca have received substantial funding for the vaccine development.

Besides, massive investments are also toward increased Covid-19 vaccine research. Hence, these pointers contribute to a lucrative growth of the market in the forecast years.

Competitive Landscape

According to MarkNtel Advisors, the major leading players in the global COVID-19 Vaccine market are AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc. Pfizer, Bharat Biotech, Serum Institute of India, etc.

Key Questions Answered in the Market Research Report:

  1. What are the primary overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global COVID-19 Vaccine Market?
  2. What are the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global COVID-19 Vaccine Market? 
  4. Who are the key competitors, their key strengths and weaknesses, and how they perform in the Global COVID-19 Vaccine Market based on the competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the Global COVID-19 Vaccine Market study?

Market Outlook, Segmentation and Statistics 

  • Impact of COVID-19 on Global COVID-19 Vaccine Market
  • Market Size & Analysis
    • By Revenue
  • Market Share & Analysis
    • By Vaccine Type
      • Whole-microbe Approach
        • Inactivated COVID-19 Vaccine
        • Live Attenuated COVID-19 Vaccine
        • Viral Vector-Based COVID-19 Vaccine
      • Protein Subunit Approach
      • Genetic Approach (Nucleic Acid Vaccine)
    • By Patient Class
      • Senior Citizens
      • Adults
      • Paediatrics
    •  By End User
      • Academic & Research Institutes
      • Vaccination Centres
      • Clinics
      • Hospitals
      • Others
    • By Region
      • North America COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • The US COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Canada COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Mexico COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
      • South America COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Brazil COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
      • Europe COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • The UK COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Germany COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • France COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Italy COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Spain COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Russia COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
      • Asia-Pacific COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • China COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • South Korea COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • Japan COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • India COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
      • Middle East & Africa COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • GCC COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
        • South Africa COVID-19 Vaccine Market Outlook, 2016-2026F (USD Billion)
    • By Competitors
      • Competition Characteristics
      • Market Share & Analysis
      • Competitive Metrix
  • Global COVID-19 Vaccine Market Hotspots & Opportunities
  • Global COVID-19 Vaccine Market Regulations & Policy
  • Key Strategic Imperatives for Success and Growth
  • Global Competition Outlook
    • Competition Matrix
    • Company Profile

Frequently Asked Questions

A. The historical data has been provided since 2016, while the base year is 2020, and the data forecast is up to 2026.

A. The market size/industry size or the market value is measured in terms of USD Billion. 

A. The Global COVID-19 Vaccine Market is expected to witness exponential growth during (2021-26).

A. AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc., Pfizer, Bharat Biotech, Serum Institute of India are few of the leading players in the Global COVID-19 Vaccine Market.

A. Hospitals are likely to attain the highest CAGR during the forecast period and maintain their significant market share.

A. Asia-Pacific continues to grow at the highest CAGR, offering immense opportunities for market players of the Global COVID-19 Vaccine Market.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Preface
  3. Executive Summary
  4. Impact of COVID-19 on Global COVID-19 Vaccine Market
  5. Global COVID-19 Vaccine Market Government Regulations
  6. Global COVID-19 Vaccine Market Trends & Insights
  7. Global COVID-19 Vaccine Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  8. Global COVID-19 Vaccine Market Hotspot & Opportunities
  9. Global COVID-19 Vaccine Market Analysis 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
        1. Whole-microbe COVID-19 Vaccine
          1. Inactivated COVID-19 Vaccine
          2. Live Attenuated COVID-19 Vaccine
          3. Viral Vector-Based COVID-19 Vaccine
        2. Protein Subunit COVID-19 Vaccine
        3. Genetic Approach (Nucleic Acid Vaccine)
      2. By Patient Class
        1. Senior Citizens
        2. Adults
        3. Paediatrics
      3.  By End User
        1. Academic & Research Institutes
        2. Vaccination Centres
        3. Clinics
        4. Hospitals
        5. Others
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
  10. North America COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. The US COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Canada COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. Mexico COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  11. South America COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. Brazil COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Rest of South America COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  12. Europe COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. UK COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Germany COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. France COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        4. Italy COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        5. Spain COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        6. Russia COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        7. Rest of Europe COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  13. Middle East & Africa COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. GCC COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. South Africa COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  14. Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. India COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. China COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. Japan COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        4. South Korea COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        5. Rest of Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  15. Global COVID-19 Vaccine Market Key Strategic Imperatives for Success & Growth
  16. Competition Outlook
    1. Competition Matrix
    2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. AstraZeneca Plc
      2. Johnson & Johnson Inc.
      3. Novavax
      4. BioNTech
      5. Moderna
      6. Glaxo Smith Kline Plc
      7. CSL Ltd.
      8. Abbott Laboratories
      9. Daiichi Sankyo Company Ltd
      10. Astellas Pharma Inc.
      11. Pfizer
      12. Bharat Biotech
      13. Serum Institute of India 
  17. Disclaimer
Global COVID-19 Vaccine Market Segmentation